Navigation Links
Top Indian Cancer Hospital to Introduce Advanced Radiosurgery Treatments With Novalis Tx from Varian Medical Systems and BrainLAB
Date:10/28/2008

MUMBAI, India, Oct. 28 /PRNewswire/ -- One of India's leading cancer hospitals will expand its program of advanced whole-body radiosurgery with the acquisition of a Varian/BrainLAB Novalis Tx(TM) radiosurgery platform. Tata Memorial Hospital in Mumbai is currently constructing a new facility to house the new device and plans to begin treatments in March next year.

The hospital, which currently delivers radiotherapy using three Varian Clinac(R) linear accelerators and four telecobalt devices, has been carrying out stereotactic radiotherapy on Clinac accelerators since 2000, mainly for brain tumor patients. The acquisition of the new Novalis Tx platform, which was ordered in March, will enable clinicians at Tata to expand this program by routinely delivering state-of-the-art stereotactic radiosurgery to combat both cranial and extra-cranial tumors.

"The new machine will enable us to offer the most modern and advanced radiotherapy and radiosurgery treatments to fight cancer," says Professor S.K. Shrivastava, head of Tata Memorial's Department of Radiation Oncology. "It means our patients will receive very advanced treatments and we can carry out both straightforward and complex cases on the same device, which improves access and efficiency."

Professor Shrivastava added, "We decided to acquire the Novalis Tx because this equipment is a technological marvel and an excellent combination of two leading suppliers of stereotactic radiosurgery technology. We have a history of introducing advanced radiotherapy treatments such as 3D-CRT and intensity-modulated radiotherapy and this move is another step in ensuring our patients receive highly accurate and effective treatments."

Varian and BrainLAB joined forces late last year to introduce the Novalis Tx and Tata Memorial is the first hospital in India to order this advanced solution. Tata Memorial treats over 16,000 new cancer patients each year, with head & neck, breast and cervical cancers th
'/>"/>

SOURCE Varian Medical Systems
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. SEAL Indiana Reports More Than Half of Indianapolis Area School Kids Treated by Program Have Moderate or Severe Dental Decay
2. Consumers Life Expands Healthcare Network in Northeast Indiana
3. Indian spice reduces size of hemorrhagic stroke
4. Indiana Tobacco Prevention and Cessation Awards Grant to Clarian Tobacco Control Center
5. Satyam Launches Comprehensive, Mobile Healthcare Program for Rural Indians
6. Global Leader In Age Management Announces New Indiana Medical Center
7. From Jet Engines to Search Engines, ORBIS-FedEx-Indiana University Join Forces to Fight Unnecessary Childhood Blindness
8. Indiana State Medical Association and AARP Urge Reconsideration of Bill to Protect Seniors Access to Doctors and Improve Medicare
9. Grubb & Ellis Healthcare REIT Acquires Medical Portfolio 3 in Indianapolis
10. J.D. Power and Associates Reports: A Vast Majority of Southern California Indian Gaming Casino Customers Express Desire for a Smoke-Free Environment
11. Indiana University to host national biorepository for gene therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)... opportunity for you to change your life - After j...u will experience a noticeable relief from the ter...sterol levels and blood pressure will return to no...will finally be freed from the health concerns tha... , Miami, FL (PRWEB) July ...
(Date:7/3/2009)...re reform details emerge, more entrepreneurs are w...nd business insurance premiums. Now, they are gett...as the Small Business Health Insurance Network to ...olis, Minn. (PRWEB) July 3, 2009 -- The health car...hich has entrepreneurs worried about how this will...
(Date:7/2/2009).../ -- Recent news reports have highlighted the impo...physicians meet high standards in their chosen are...Medical Specialties (ABMS), which coordinates and ...evelop and implement educational and professional ...physician specialists. Certification by an ABMS M...
(Date:7/2/2009)...e/ -- Dr Daniel Goldberg, a leading New Jersey oph...e the effectiveness of using 5% Betadine irrigatio...e, highly contagious and often severe form of conj... impairment due to corneal involvement. , , Oph...ster to participate in the Betadine for EKC study....
Breaking Medicine News(10 mins):Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 4Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4Health News:Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study 2
...mmon fear in women that their sexual performance i... international journal of obstetrics and gynecolog... affects a woman's sexual function in the long ter...en who had given birth for the first time. They fo...
... Tech researcher Stefan Duma has been named as one...or his biomechanics innovations.// Technology Rev...anical engineering and founding director of the Vi...Biomechanics, to the 2006 'TR35' list of the top 3...
...lisher John Wiley & Sons, Inc., confirms their pla...D for providing subscriptions of their journal.// ...had announced on the 6th of September their plans ...rican Society for Paediatric Gastroenterology, Hep...
...s at St. Louis Children's Hospital and Washington ...quested authorities not to allow children under th...). This call was issued after a 10-year review of ...ence or training in driving motorized vehicles, an...
Other Medicine News:Health News:A young scientist recognized for biomechanics innovations 2Health News:A young scientist recognized for biomechanics innovations 3Health News:Call To Ban Use Of ATVs By Children 2
(Date:6/28/2009)..., CHIPPENHAM, England and TOKYO, June 29 /PRN...ones for Both Companies , Sosei Group Corpo...ura,Group plc ("Vectura"; LSE: VEC) announce the ...artis, with NVA237, a once-daily, long-acting musc...onic obstructive pulmonary disease,(COPD). NVA237...
(Date:6/26/2009)..., --Combination of Inherited and New Genetic Muta...26 More pieces in the c...he latest study from a research team including gen...hia, the University of Pennsylvania School of Me...s study identified 27 different genetic regions wh...
(Date:6/25/2009)..., PRINCETON, N.J., June 25 "Congr...large pharmaceutical companies to cut prescription...ident of NeoStrata Company, Inc. "We thought you s...ersey that,s done the same for psoriasis sufferers... NeoStrata Company, Inc., and the submission of th...
(Date:6/24/2009)..., LEUVEN, Belgium, June 25 /PRNewswire-FirstC...oGenics, Lead Product for the,Non-Surgical Treatm..., ThromboGenics NV (Euronext Brussels: THR)...y and development of innovative treatments for eye...today that its lead product,microplasmin, which i...
Breaking Medicine Technology:Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4More Gene Mutations Linked to Autism Risk 2More Gene Mutations Linked to Autism Risk 3More Gene Mutations Linked to Autism Risk 4Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform 2ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 2ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 3Court issues final order approving Biomiras move to U S and name change to Oncothyreon 7653 1Court issues final order approving Biomiras move to U S and name change to Oncothyreon 7653 2Court issues final order approving Biomiras move to U S and name change to Oncothyreon 7653 3URAC Names Sensei for Weight Loss as a Finalist in First Ever Best Practices in Consumer Empowerment and Protection Awards 7648 1URAC Names Sensei for Weight Loss as a Finalist in First Ever Best Practices in Consumer Empowerment and Protection Awards 7648 2URAC Names Sensei for Weight Loss as a Finalist in First Ever Best Practices in Consumer Empowerment and Protection Awards 7648 3Teen Birth Rates Up for First Time in 14 Years U S Reports 7643 1Teen Birth Rates Up for First Time in 14 Years U S Reports 7643 2Teen Birth Rates Up for First Time in 14 Years U S Reports 7643 3Atomic bomb survivor scientists mark 60 years of long term radiation study 1470 1Atomic bomb survivor scientists mark 60 years of long term radiation study 1470 2
...HAPEL HILL, N.C., US, March 06, 2007,/PRNewswire/ ...d,Lantibio, Inc. ("Lantibio") today announced posi...double-blinded Phase II clinical,study of Moli1901...s ("CF"). Moli1901 is being developed by AOP Orpha...n agreement with,Lantibio. The study, performed at...
...IRE)--Mar 7, 2007 - BioLineRx Ltd.,(TASE:BLRX), Is...today pre-clinical data from trials of BL-1040 dem... deterioration of the myocardium,after a myocardia...,dilatation and eventual heart failure in a pig mo...Neufeld Cardiac Research,Institute at Sheba Medica...
Other Medicine Technology:AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 2AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 3AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 4BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 2BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 3
...he Prostate Specific Antigen (total PSA) test, has...tients with prostate cancer. Of the different PSA ... the first approved for the detection of prostate ...l examination (DRE) in men aged 50 years or older....
Designed specifically for use with children ages,3 and up The patient is asked to distinguish between a "Raised E" and a non stereo target.
Test and Evaluate Random Dot Stereo Depth Perception for Both,Gross Stereopsis (2500 to 1200 sec of arc) and Fine Depth,Perception. , ,The Test Includes:, Graded Circle Test (800 to 40 sec
... only handheld non-contact tonometer with over 17 ...treamlined, quiet and now, with constant puff mon... gentle puff of air. You can prove how gentle the ... before you start. With the new soft puff they wi...
Medicine Products: